Highest Net Income
multiline_chartThese high-earning enterprises stand out for their remarkable profitability and demonstrate their ability to generate substantial net income.
| name | Price | $ Change | % Change | Market Cap | Volume | Avg. Volume | arrow_downwardNet Income | Technicals | Dividend Y | ROI 1Y | Score language | Last 7 Days | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DZSIDZS | $0.60 | -$0.05 | arrow_drop_down7.69% | $25.10M | 0.00 | 8.17K | -$135.21M | Neutralremove | - | -52.94% | AI Analysis | |||||
GLUEMonte Rosa Therapeutics | $7.92 | -$0.50 | arrow_drop_down5.89% | $507.46M | 282.00K | 8.21 | -$135.35M | Neutralremove | - | 132.52% | AI Analysis | |||||
TARSTarsus Pharmaceuticals | $44.19 | -$2.48 | arrow_drop_down5.32% | $1.69B | 440.32K | 44.19 | -$135.89M | Neutralremove | - | 146.62% | AI Analysis | |||||
AVIRAtea Pharmaceuticals | $3.26 | -$0.04 | arrow_drop_down1.35% | $275.77M | 124.79K | 3.25 | -$135.95M | Neutralremove | - | 8.83% | AI Analysis | |||||
GETRGetaround | $0.06 | $0.00 | arrow_drop_up7.07% | $5.70M | 44.22K | 84.66K | -$136.06M | Neutralremove | - | -58.32% | AI Analysis | |||||
IPSCCentury Therapeutics | $1.23 | -$0.02 | arrow_drop_down1.58% | $107.13M | 295.82K | 1.25 | -$136.67M | Neutralremove | - | -5.72% | AI Analysis | |||||
LEGLeggett & Platt | $11.89 | $0.08 | arrow_drop_up0.72% | $1.56B | 380.04K | 11.84 | -$136.80M | Neutralremove | 1.68% | -48.92% | AI Analysis | |||||
PHRPhreesia | $17.72 | -$3.29 | arrow_drop_down15.66% | $1.01B | 525.42K | 18.44 | -$136.88M | Neutralremove | - | 12.13% | AI Analysis | |||||
 FRSHFreshworks | $15.87 | -$0.44 | arrow_drop_down2.69% | $4.81B | 1.60M | 16.04 | -$137.43M | Neutralremove | - | -13.34% | AI Analysis | |||||
AGFirst Majestic Silver | $6.39 | -$0.05 | arrow_drop_down0.85% | $1.94B | 4.88M | 6.49 | -$137.58M | Neutralremove | 0.30% | 27.13% | AI Analysis | |||||
MRCYMercury Systems | $39.95 | -$0.87 | arrow_drop_down2.14% | $2.42B | 88.22K | 40.76 | -$137.64M | Neutralremove | - | 15.12% | AI Analysis | |||||
LICYLi-Cycle Holdings | $2.12 | -$0.19 | arrow_drop_down8.44% | $49.45M | 580.57K | 2.21 | -$138.00M | Neutralremove | - | -59.73% | AI Analysis | |||||
GRTSGritstone Oncology | $0.03 | -$0.01 | arrow_drop_down30.72% | $3.80M | 61.01M | 0.03 | -$138.49M | Neutralremove | - | -97.64% | AI Analysis | |||||
ITCIIntra-Cellular Therapies | $85.26 | -$2.36 | arrow_drop_down2.69% | $9.04B | 181.24K | 85.82 | -$139.67M | Neutralremove | - | 50.37% | AI Analysis | |||||
XPERXperi | $8.22 | -$0.15 | arrow_drop_down1.79% | $370.74M | 77.12K | 8.29 | -$139.68M | Neutralremove | - | -11.93% | AI Analysis | |||||
STEMStem | $0.35 | -$0.01 | arrow_drop_down4.18% | $60.21M | 3.04M | 0.36 | -$140.41M | Neutralremove | - | -88.39% | AI Analysis | |||||
PLPlanet Labs PBC | $2.91 | -$0.09 | arrow_drop_down3.16% | $880.42M | 2.08M | 2.86 | -$140.50M | Neutralremove | - | 20.45% | AI Analysis | |||||
CDMOAvid Bioservices | $12.12 | $0.18 | arrow_drop_up1.50% | $772.90M | 1.56M | 12.10 | -$140.75M | Neutralremove | - | 121.66% | AI Analysis | |||||
XXII22nd Century Group | $0.09 | -$0.00 | arrow_drop_down2.21% | $4.21M | 1.77M | 0.09 | -$140.77M | Neutralremove | - | -98.51% | AI Analysis | |||||
MRNSMarinus Pharmaceuticals | $0.31 | $0.01 | arrow_drop_up3.40% | $16.91M | 957.10K | 0.30 | -$141.40M | Buykeyboard_arrow_up | - | -95.10% | AI Analysis |
Showing 4481-4500 of 4977
Results per page:
About Highest Net Income
Stocks with the highest net income, also known as stocks ranking in the cash, are the cream of the crop in the market. Net income represents a company's profitability after deducting all expenses, making it a crucial measure of financial success.
Investors are drawn to companies with impressive net income figures, as it demonstrates their ability to generate substantial profits from their core operations. High net income stocks often attract long-term investors seeking stable and lucrative opportunities.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools